Company Overview and News
Southwestern Energy (SWN) is set to report its 1Q18 earnings on April 26, 2018, after the market closes. For 1Q18, excluding any one-time items, the current consensus net income estimate for Southwestern Energy is ~$136 million. On a year-over-year basis, SWN is expected to report ~56% higher profits when compared with 1Q17’s adjusted net income of ~$87 million. Even on a sequential basis and excluding any one-time items, SWN’s 1Q18 consensus net income estimate is much higher by ~116% from a profit of ~$63 million in 4Q17.
Chesapeake Energy (CHK) stock fell 1.6% in the week ended April 17, 2018, during a volatile week for crude oil (UCO) prices. During the week, crude oil rose following geopolitical tensions, which, as the week progressed, eased a bit, causing crude oil prices to fall.
On April 17, 2018, natural gas May 2018 futures closed at a premium of ~$0.1 to May 2019 futures. The difference is called the “futures spread.” On April 10, 2018, the futures spread was at a premium of ~$0.03. Between April 10 and April 17, 2018, natural gas May futures rose 3.1%.
April 17 (Reuters) - Pennsylvania regulators said on Tuesday they will set up a grant program with the $12.6 million that Energy Transfer Partners LP paid as a penalty for permit violations during construction of the Sunoco Mariner East 2 natural gas liquids pipeline:
For 1Q18, Wall Street analysts expect Range Resources (RRC) to report revenues of ~$695 million. On a YoY (year-over-year) basis, Range Resources’ 1Q18 revenue expectations are ~14% higher compared to its 1Q17 revenues of ~$607 million. Sequentially, Range Resources’ 1Q18 revenue expectations are ~16% higher compared to its 4Q17 revenues of ~$600 million.
Range Resources (RRC) is scheduled to report its 1Q18 earnings on April 25, 2018, after the market closes. For 1Q18, excluding any one-time items, the current consensus net income estimate for Range Resources is ~$105 million. On a YoY (year-over-year) basis, Range Resources is expected to report ~72% higher profits compared to the adjusted net income of ~$61 million in 1Q17. On a sequential basis and excluding any one-time items, Range Resources’ 1Q18 consensus net income estimate is ~91% higher than the profit of ~$55 million in 4Q17.
Future Market Insights assesses the shale gas hydraulic fracturing market in the U.S, Canada, and China in its newly published report titled, “Shale Gas Hydraulic Fracturing Market: Canada, US, and China Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027.” According to the report, the US market production value is anticipated to expand from 18,059 BCF (2017) at a 9.8% CAGR, Canadian market's production volume of 213.
Oil Price Oil prices are up over 5% in the last two days for a number of differing reasons. As I noted yesterday there appears to be some degree of conciliation in the tariff wars between the USA and China but don't hold your breath. Much more important is the jacking up of bad relations between international powers over Syria, importantly bad as no one appears quite what to do about it. It seems that whilst further attacks by the US would be counterproductive there is a feeling over there that something has to be done in the lesson teaching department so expect military reprisals sometime soon.
Range, an international oil and gas company with assets in Trinidad and Indonesia, and an oilfield services business in Trinidad, is pleased to announce that it has reached an agreement with Agencia Nacional de Hidrocarburos (“ANH”) to settle all outstanding claims and disputes between ANH and the consortium of Optima Oil Corporation and the Company (the “Consortium”).
Range Resources Ltd (LON:RRL) told investors it has reached an agreement with Colombia’s Agencia Nacional de Hidrocarburos (ANH) to settle all outstanding claims and disputes between ANH and the consortium of Optima Oil Corporation and the company.
Natural Gas Liquids (NGLs) Industry report offers a comprehensive insight into the development policies and plans in addition to manufacturing processes and cost structures. On the basis of product, this report displays the Cost Structure, Sales Revenue, Sales Volume, Gross Margin, market share and growth rate.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...